- €6.65bn
- €7.52bn
- $2.09bn
Brief: Qiagen Launches New Qiacuity Digital Pcr Kits And Updated Software To Expand Use By Biopharma And Food Safety Customers
Brief: Qiagen And Element Biosciences Partner To Offer Complete Next-Generation Sequencing Workflows For Aviti System
Qiagen rises after Q3 sales beat consensus, guidance confirmation
Brief: Qiagen Reports 5% Revenue Growth In Non-Covid Portfolio To 442 Million USD In Third Quarter
Brief: Qiagen And Myriad Genetics Partner To Advance Development Of Companion Diagnostics For Cancer
Live Markets: Is the worst over for medical equipment companies?
Brief: QIAGEN Launches QuantiFERON-EBV RUO Assay, Facilitating Research Of Cell-Mediated Immune Response To Epstein-BARR Virus
HSBC prefers Biomerieux as healthcare equipment sector struggles with COVID unwind
Europe Research Roundup: Biomerieux, Eurofins Scientific, OCI NV
Brief: Qiagen Extends AI Capabilities Of Its NGS Interpretation Software QCI Interpret To Enable Clinical Exome Completeness
Brief: Qiagen’S Quantiferon Solutions Recommended For Use By Kidney Specialists In Tunisia
Europe Research Roundup: Adyen NV, Prosus NV, Spectris
Brief: Qiagen Receives FDA Approval For Companion Diagnostic To Blueprint Medicines’ Ayvakit In Gastrointestinal Stromal Tumors
Brief: Bio-Rad And QIAGEN Announce Patent Settlement And Cross-Licensing Agreement
Brief: QIAGEN Expands Range Of Digital PCR Kits And Services For The Biopharma Industry
Brief: FBI Approves QIAGEN’S ForensSeq MainstAY Workflow For U.S. National DNA Index System
MS upgrades Qiagen seeing growth beyond COVID testing
US shares of Qiagen rise on Q1 results beat
Brief: QIAGEN Reports Q1 Results